🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to assess the relative bioavailability of two 7.5 mg meloxicam tablet...
Status
Completed
Location
Multiple Locations
Start Date
1999-06
Trial ID
NCT02276352
Treatments Being Tested
The objective of this study was to investigate the influence of meloxicam o...
Status
Completed
Location
Multiple Locations
Start Date
2002-07
Trial ID
NCT02187562
Study to assess the effect of food on the pharmacokinetics of meloxicam aft...
Status
Completed
Location
Multiple Locations
Start Date
2001-06
Trial ID
NCT02181322
Treatments Being Tested
In this clinical study, meloxicam will be used to the patients who are olde...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT02298218
Treatments Being Tested
The primary purpose of this study was to evaluate the effect of meloxicam t...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT02183155
Treatments Being Tested
This was a Phase 1b/2, randomized, blinded, active-controlled study. Phase ...
Status
Completed
Location
Arizona Research Center
Start Date
2020-05-08
Trial ID
NCT04398329
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of a low d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02405793
Treatments Being Tested
Approximately 120 subjects will be randomized into 1 of the following 2 tre...
Status
Unknown
Location
Holyoke Medical Center
Start Date
2023-05-09
Trial ID
NCT05863221
Treatments Being Tested
The purpose of this study is to determine whether Meloxicam \[Test\] Capsul...
Status
Completed
Location
Achieve Clinical Research, LLC
Start Date
2013-02
Trial ID
NCT01787188
Treatments Being Tested
Study to investigate dose-proportionality over the dosage range 7.5 mg to 2...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT02181309
Treatments Being Tested